{"id":2005,"date":"2021-10-22T16:10:47","date_gmt":"2021-10-22T16:10:47","guid":{"rendered":"https:\/\/www.awkolaw.com\/?page_id=2005"},"modified":"2023-06-27T20:27:56","modified_gmt":"2023-06-27T20:27:56","slug":"elmiron-lawsuit","status":"publish","type":"page","link":"https:\/\/www.awkolaw.com\/litigation-areas\/defective-drugs\/elmiron-lawsuit\/","title":{"rendered":"Elmiron"},"content":{"rendered":"
[et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” background_color=”gcid-240a9ec6-8ca4-46e7-b795-ccc98c8b36c4″ use_background_color_gradient=”on” background_color_gradient_direction=”352deg” background_color_gradient_stops=”gcid-240a9ec6-8ca4-46e7-b795-ccc98c8b36c4 45%|#ffffff 100%” background_color_gradient_start=”gcid-240a9ec6-8ca4-46e7-b795-ccc98c8b36c4″ background_color_gradient_start_position=”45%” background_color_gradient_end=”#ffffff” background_enable_image=”off” background_size=”contain” background_position=”center_left” global_colors_info=”{%22gcid-240a9ec6-8ca4-46e7-b795-ccc98c8b36c4%22:%91%22background_color%22,%22colorStart%22%93}”][et_pb_row column_structure=”2_3,1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”2_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][dsm_block_reveal_text block_reveal_text=”Elmiron Lawsuit” heading_html_tag=”h1″ block_reveal_color=”gcid-546ba48d-cfd8-4b8f-9a94-622a690b5247″ _builder_version=”4.20.4″ _module_preset=”default” header_font=”Merriweather||||||||” header_text_color=”gcid-b3bc4740-83c0-49fc-94f2-b1bc7d48ace9″ header_font_size=”36px” header_line_height=”1.3em” custom_margin=”||16px|25px|false|false” global_colors_info=”{%22gcid-546ba48d-cfd8-4b8f-9a94-622a690b5247%22:%91%22block_reveal_color%22%93,%22gcid-b3bc4740-83c0-49fc-94f2-b1bc7d48ace9%22:%91%22header_text_color%22%93}”][\/dsm_block_reveal_text][dsm_block_reveal_text block_reveal_text=”Patients Taking Elmiron May Develop A Rare But Serious Eye Disease Called Retinal Maculopathy” block_reveal_color=”gcid-546ba48d-cfd8-4b8f-9a94-622a690b5247″ _builder_version=”4.20.4″ _module_preset=”default” header_font=”||||||||” header_text_color=”gcid-b3bc4740-83c0-49fc-94f2-b1bc7d48ace9″ header_line_height=”1.3em” custom_margin=”|||25px|false|false” global_colors_info=”{%22gcid-546ba48d-cfd8-4b8f-9a94-622a690b5247%22:%91%22block_reveal_color%22%93,%22gcid-b3bc4740-83c0-49fc-94f2-b1bc7d48ace9%22:%91%22header_text_color%22%93}”][\/dsm_block_reveal_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_button button_url=”#evaluation” button_text=”FREE CASE EVALUATION” _builder_version=”4.16″ _module_preset=”default” custom_button=”on” button_text_color=”gcid-b3bc4740-83c0-49fc-94f2-b1bc7d48ace9″ button_border_color=”#FFAF02″ custom_margin=”10px||||false|false” global_colors_info=”{%22gcid-546ba48d-cfd8-4b8f-9a94-622a690b5247%22:%91%22button_bg_color%22,%22button_bg_color%22%93,%22gcid-b3bc4740-83c0-49fc-94f2-b1bc7d48ace9%22:%91%22button_text_color%22%93}”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”40px|||||” global_colors_info=”{}”][et_pb_row _builder_version=”4.20.4″ _module_preset=”default” custom_margin=”0px||||false|false” custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.17.1″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n
Recent studies show that patients taking Elmiron may develop a rare but serious eye disease called retinal maculopathy. <\/span><\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.16″ _module_preset=”default” background_color=”gcid-240a9ec6-8ca4-46e7-b795-ccc98c8b36c4″ background_enable_color=”on” global_colors_info=”{%22gcid-b3bc4740-83c0-49fc-94f2-b1bc7d48ace9%22:%91%22header_2_text_color%22%93,%22gcid-240a9ec6-8ca4-46e7-b795-ccc98c8b36c4%22:%91%22background_color%22%93}”]<\/p>\n Elmiron<\/b> (also known as <\/span>pentosan polysulfate sodium<\/span><\/i>, or PPS) is a drug prescribed to treat osteoarthritis and interstitial cystitis, or \u201cpainful bladder syndrome.\u201d<\/span><\/p>\n [\/et_pb_text][et_pb_text ul_type=”square” _builder_version=”4.17.1″ _module_preset=”default” ul_font_size=”16px” global_colors_info=”{%22gcid-b3bc4740-83c0-49fc-94f2-b1bc7d48ace9%22:%91%22header_2_text_color%22%93}”]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.17.1″ _module_preset=”default” background_color=”gcid-240a9ec6-8ca4-46e7-b795-ccc98c8b36c4″ background_enable_color=”on” global_colors_info=”{%22gcid-b3bc4740-83c0-49fc-94f2-b1bc7d48ace9%22:%91%22header_2_text_color%22%93,%22gcid-240a9ec6-8ca4-46e7-b795-ccc98c8b36c4%22:%91%22background_color%22%93}”]<\/p>\n In 2017 the Emory Eye Center in Atlanta, Georgia began studying a new eye disease, \u201cretinal maculopathy\u201d in patients.\u00a0 Emory discovered that every patient in the study with this eye disease had been taking Elmiron.\u00a0 Shortly thereafter, Kaiser Oakland found even more patients in their database with retinal maculopathy and eye damage who has taken Elmiron.\u00a0 In December 2019, the Interstitial Cystitis Network conducted a survey of its members taking Elmiron, and the results were shocking:\u00a0 <\/span>over half of the patients on Elmiron who participated in the study suffered from retinal disease.<\/b><\/p>\n [\/et_pb_text][et_pb_text ul_type=”square” _builder_version=”4.17.1″ _module_preset=”default” ul_font_size=”16px” global_colors_info=”{%22gcid-b3bc4740-83c0-49fc-94f2-b1bc7d48ace9%22:%91%22header_2_text_color%22%93}”]<\/p>\n While the medical community has only recently learned of this connection, Elmiron\u2019s manufacturer Janssen has known of the link between Elmiron and eye damage for over 20 years.\u00a0 In early clinical trials of patients who took Elmiron for up to four years, both vision and eye-related adverse events were reported.<\/span><\/p>\n Although Janssen knew of the link between Elmiron and eye damage for more than 20 years, the company never added warnings to the label or conducted further research on the link between Elmiron and eye damage<\/b>.\u00a0 Instead, they ignored the risks and went on to earn billions of dollars selling Elmiron.\u00a0 Now they are facing thousands of lawsuits from patients that suffered severe eye damage.\u00a0 If you have taken Elmiron and experienced eye damage, contact us today.<\/span><\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.17.6″ _module_preset=”default” link_text_color=”#606060″ background_color=”gcid-240a9ec6-8ca4-46e7-b795-ccc98c8b36c4″ background_enable_color=”on” global_colors_info=”{%22gcid-b3bc4740-83c0-49fc-94f2-b1bc7d48ace9%22:%91%22header_2_text_color%22,%22header_2_text_color%22,%22header_2_text_color%22%93,%22gcid-240a9ec6-8ca4-46e7-b795-ccc98c8b36c4%22:%91%22background_color%22%93,%22gcid-546ba48d-cfd8-4b8f-9a94-622a690b5247%22:%91%22link_text_color__hover%22%93}” link_text_color__hover_enabled=”on|hover” link_text_color__hover=”#ffaf02″]<\/p>\n Drug manufacturers are responsible for ensuring the safety and efficacy of their products before marketing them for public consumption. Failure to do so is considered negligent and grounds for litigation.\u00a0 The attorneys of Aylstock, Witkin Kreis & Overholtz<\/a> handle litigation across the United States for victims injured by defective pharmaceuticals<\/a> and medical devices<\/a>.\u00a0 We have successfully represented and obtained substantial compensation for thousands of patients who have been harmed by prescription drugs<\/a>.<\/span><\/p>\n If you believe that you may have suffered vision loss or have been diagnosed with macular degeneration or a similar condition, please call us today at <\/span>1-877-810-4808 <\/b>or email us at <\/span>ElmironClaim@awkolaw.com<\/span> so that we may provide you with additional information about your legal rights.<\/span><\/p>\n [\/et_pb_text][et_pb_divider color=”gcid-546ba48d-cfd8-4b8f-9a94-622a690b5247″ divider_weight=”2px” _builder_version=”4.16″ _module_preset=”default” width=”100%” global_colors_info=”{%22gcid-546ba48d-cfd8-4b8f-9a94-622a690b5247%22:%91%22color%22%93}”][\/et_pb_divider][et_pb_text _builder_version=”4.21.0″ _module_preset=”default” link_font=”||||||||” link_text_color=”#606060″ link_font_last_edited=”off|desktop” global_colors_info=”{%22gcid-b3bc4740-83c0-49fc-94f2-b1bc7d48ace9%22:%91%22header_2_text_color%22,%22header_2_text_color%22%93,%22gcid-546ba48d-cfd8-4b8f-9a94-622a690b5247%22:%91%22link_text_color__hover%22%93}” link_text_color__hover_enabled=”on|hover” link_text_color__hover=”#ffaf02″]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ module_id=”evaluation” _builder_version=”4.17.4″ _module_preset=”default” custom_padding=”0px||||false|false” global_module=”3222″ saved_tabs=”all” global_colors_info=”{}”][et_pb_row _builder_version=”4.17.4″ _module_preset=”default” custom_margin=”||||false|false” custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.17.4″ _module_preset=”default” custom_padding=”0px|25px||25px|false|false” custom_padding_tablet=”|||25px|false|false” custom_padding_phone=”” custom_padding_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n [\/et_pb_text][et_pb_code _builder_version=”4.17.4″ _module_preset=”default” custom_padding=”|25px||25px|false|true” global_colors_info=”{}”]What is Elmiron?<\/h2>\n
<\/h2>\n
Elmiron Possible Injuries & Side Effects<\/h2>\n
\n
Recent Studies of Elmiron<\/h2>\n
<\/h2>\n
The Manufacturer Knew of the Link Between Elmiron and Eye Damage<\/span><\/h2>\n
Elmiron Lawsuits<\/h2>\n
References<\/h2>\n
\n
Free Case Evaluation<\/h2>\n